Voyager Biomedical
Houston, US · Founded 2016 · Delaware corporation · 1 known investors
Find your way into Voyager Biomedical
203 people in our graph share verified history with the Voyager Biomedical team — schools, employers, funds. One of them is your warm intro.
Doug Evansunlockedknows Monica Klos · together at Vesper Medical (overlapped)
×3knows the team · via Intact Vascular
×7knows the team · via Villanova University
knows the team · via Vesper Medical
Voyager Biomedical develops VenaSure, an implanted porous titanium device that creates a palpable access window to guide reliable cannulation of AV fistulas for hemodialysis patients. The device is intended for use in dialysis centers and home dialysis to reduce needle-related vein damage during vascular access.
Founders & leadership
MP
Marcus PennaExecutive
MK
Monica KlosVP of FinanceMonica Klos is Executive Officer at Voyager Biomedical, which develops implanted vascular access devices for hemodialysis patients. She brings more than 30 years of accounting and finance experience, including work at Big Four firms and in both public and private companies, with expertise in corporate accounting, financial reporting, budgeting, and operations management.
LS
Linda SpainNamed on SEC filing
Board
AG
Ashok GowdaBoard directorPartner, MedTex Ventures; CEO, Biotex Inc. at MedTex Ventures LLC
BS
Bruce ShookBoard director
TU
Trevor UhlBoard directorCo-Founder and CFO at MedTex Ventures LLC
AG
Alan GlowczwskiBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$6.8M disclosed across 2 rounds · 2019–2025
▶$5.8MraisedApr 2025 · 18 investors · Other Health CareRule 506(b)
▶$5.8MraisedApr 2025 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marcus PennaExecutive Officer, Director
- Monica KlosExecutive Officer
- Ashok GowdaDirector
- Bruce ShookDirector
- Trevor UhlDirector
- Alan GlowczwskiDirector
- Offering amount
- $9.8M
- Amount sold
- $5.8M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$995KraisedOct 2020 · 15 investors · Other Health CareRule 506(b)
▶$995KraisedOct 2020 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nathan BorgfeldPromoter
- Robert SmithPromoter
- April LoveladyPromoter
- Alan GlowczwskiExecutive Officer, Director
- Linda SpainExecutive Officer, Director
- Ashok GowdaExecutive Officer, Director, Promoter
- Peter SmithPromoter
- Amount sold
- $995K
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Voyager Space6 shared keywordsVoyager Technologies is a defense and space technology company developing capabilities in advanced electronics, mission management, orbital data centers, space exploration, spectrum dominance, and strategic systems across air, land, space, and cyber domains. It also operates the Starlab commercial space station program.
Bioworld6 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Rf Surgical4 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Seeking Alpha4 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Globaldata4 shared keywordsGlobalData provides an AI-powered intelligence platform that delivers research, market analysis, and predictive insights to enterprises across industries. The platform combines proprietary data, in-house subject matter experts, and AI tools to support critical business decisions.
Companies competing with Voyager Biomedical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Voyager Biomedical do?
- Voyager Biomedical develops VenaSure, an implanted porous titanium device that creates a palpable access window to guide reliable cannulation of AV fistulas for hemodialysis patients. The device is intended for use in dialysis centers and home dialysis to reduce needle-related vein damage during vascular access.
- Who are Voyager Biomedical's investors?
- Voyager Biomedical's investors include MedTex Ventures LLC.
- How much funding has Voyager Biomedical raised?
- Voyager Biomedical has disclosed $6.8M raised across 2 rounds.
- Where is Voyager Biomedical headquartered?
- Voyager Biomedical is headquartered in Houston, US.